{"entity":{"id":"bruno-sangro","kind":"person","name":"Bruno Sangro","aka":[],"tldr":"Hepatologist at Clínica Universidad de Navarra and a leading international investigator in liver cancer systemic therapy and radioembolisation.","summary":"Bruno Sangro leads translational research on the Executive Committee of the Cancer Center Clínica Universidad de Navarra and directs the Liver Unit at the clinic. He has been a principal investigator in major hepatocellular carcinoma trials, including immunotherapy combinations, and has contributed to EASL and ESMO guidelines for liver cancer.","asOf":"2026-09-10","links":[{"label":"Institution profile","url":"https://cancercenter.cun.es/cancer-center/organigrama"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Sangro+B%5BAuthor%5D"}],"tags":["clinician-scientist","liver cancer","immunotherapy"],"related":[],"cancers":["hcc","cholangiocarcinoma"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["cun-navarra"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Translational Research lead, Executive Committee","institutionId":"cun-navarra","specialisms":["Hepatocellular carcinoma","Hepatology","Liver cancer immunotherapy"],"profiles":[{"label":"Institution profile","url":"https://cancercenter.cun.es/cancer-center/organigrama"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Sangro+B%5BAuthor%5D"}],"papers":[{"title":"Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma","journal":"Annals of Oncology","year":2024,"doi":"10.1016/j.annonc.2024.02.005"},{"title":"Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study","journal":"The Lancet","year":2025,"doi":"10.1016/s0140-6736(24)02551-0"},{"title":"Immunotherapy of Hepatocellular Carcinoma: Facts and Hopes","journal":"Clinical Cancer Research","year":2018,"doi":"10.1158/1078-0432.ccr-17-0289"}],"orcid":"0000-0002-4177-6417"},"route":"/people/bruno-sangro/","neighbours":{"cancer":[{"id":"cholangiocarcinoma","kind":"cancer","name":"Biliary tract cancer (cholangiocarcinoma)","route":"/cancers/cholangiocarcinoma/"},{"id":"hcc","kind":"cancer","name":"Hepatocellular carcinoma","route":"/cancers/hcc/"}],"institution":[{"id":"cun-navarra","kind":"institution","name":"Cancer Center Clínica Universidad de Navarra / CIMA","route":"/institutions/cun-navarra/"}]}}